Concepedia

Melanie A. Kleinschek

MA

Statistics

Publications

15

Citations

4.4K

H-Index

15

Active since

2006

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Theravance Biopharma (United States)

CTI BioPharma (Italy)

Mayo Clinic in Arizona

Leipzig University

Melanie A. Kleinschek is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in immunology, inflammation, and life sciences.

Publications per year

2006–2020

15

Publications

15

IL-23 is essential for T cell–mediated colitis and promotes inflammation via IL-17 and IL-6

David Yen, Jeanne Cheung, Heleen Scheerens et al. · Journal of Clinical Investigation · 2006 · 1.5K citations · Full text

, , +17

RORγt+ innate lymphoid cells regulate intestinal homeostasis by integrating negative signals from the symbiotic microbiota

Shinichiro Sawa, Matthias Lochner, Naoko Satoh‐Takayama et al. · Nature Immunology · 2011 · 559 citations · Full text

, , +17

IL25 elicits a multipotent progenitor cell population that promotes TH2 cytokine responses

Steven A. Saenz, Mark C. Siracusa, Jacqueline Perrigoue et al. · Nature · 2010 · 549 citations · Full text

, , +14

Circulating and gut-resident human Th17 cells express CD161 and promote intestinal inflammation

Melanie A. Kleinschek, Katia Boniface, Svetlana Sadekova et al. · The Journal of Experimental Medicine · 2009 · 456 citations · Full text

, , +12

IL-10 Elicits IFNγ-Dependent Tumor Immune Surveillance

John B. Mumm, Jan Emmerich, Xueqing Zhang et al. · Cancer Cell · 2011 · 414 citations · Full text

, , +10

1–5 of 15